BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 123 found
  Current Search:  camptosar: 123     

HTML
100%
Pfizer's net moves up strongly by 119% to US$2.8 bn in Q2
Pfizer Inc has achieved strong performance during the second quarter ended June 2008 and its net income increased by 119 per cent to US$2.8 billion from US$1.3 billion in the corresponding period of last year and reported diluted EPS of $0...
PharmaBiz:  Jul 24 2008 9:01AM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer Leans On Lipitor, Cost Cutting
Despite generic drugs and health concerns encroaching on sales in the second quarter, Pfizer managed to grow its bottom line.

On Wednesday, the New York City-based pharmaceutical giant became the third large U.S.

drug company in as many...

Forbes.com:  Jul 24 2008 2:57AM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer's quarterly earnings mushroom
BOSTON (MarketWatch) -- Pfizer, the world's largest drugmaker, reported that its second-quarter profit more than doubled, due largely to a favorable currency exchange rate and lower costs.

The New York-based drugmaker posted net income of ...

MarketWatch:  Jul 24 2008 11:44AM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer earnings soar on cost-cutting and international sales
US drug giant Pfizer has posted a strong set of results for the second quarter which shows that earnings more than doubled, thanks to healthy international sales and the positive impact of its cost-cutting measures.

Net income was up 119%...

Pharma Times:  Jul 24 2008 11:38AM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer Inc. profit more than doubles in quarter
TRENTON, N.J.Pfizer Inc.

said yesterday its second-quarter profit more than doubled as restructuring charges declined and the weak U.S.

dollar helped lift overseas revenue, offsetting new generic competition and enabling the company to...

Toronto Star Online:  Jul 24 2008 10:16AM
Matching: camptosar
Find similar documents
HTML
100%
International sales lift Pfizer 2Q profit (posted Yesterday at 9:58am)
New York-based Pfizer, the world's biggest drugmaker, said profit rose to $2.78 billion, or 41 cents per share, compared with $1.27 billion, or 18 cents per share, a year ago.

Revenue rose 9 percent, to $12.13 billion from $11.08 billion,...

Hartford Business Journal:  Jul 24 2008 10:04AM
Matching: camptosar
Find similar documents
HTML
100%
International sales lift big drug maker Pfizer's second-quarter profit
TRENTON, N.J., Pfizer on Wednesday said its second-quarter profit more than doubled as restructuring charges declined and the weak dollar helped lift overseas revenue, enabling the company to just beat Wall Street expectations.

New York...

Macro World Investor:  Jul 24 2008 9:24AM
Matching: camptosar
Find similar documents
HTML
100%
International sales lift Pfizer 2Q profit
TRENTON, N.J.

(AP) - Pfizer Inc.

on Wednesday said its second-quarter profit more than doubled as restructuring charges declined and the weak dollar helped lift overseas revenue, offsetting new generic competition and enabling the...

AOL:  Jul 24 2008 7:05AM
Matching: camptosar
Find similar documents
HTML
100%
International sales lift Pfizer 2Q profit
Pfizer Inc.

on Wednesday said its second-quarter profit more than doubled as restructuring charges declined and the weak dollar helped lift overseas revenue, offsetting new generic competition and enabling the company to just beat Wall...

Town Hall:  Jul 24 2008 5:32AM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer doubles profit on strong international sales
Pfizer, the US pharmaceuticals giant, said Wednesday its second-quarter net profit more than doubled due to surging international sales and reaffirmed its 28 outlook.

Net profit in the April-June period was 2.776 billion dollars, a...

Yahoo! Canada:  Jul 24 2008 1:54AM
Matching: camptosar
Find similar documents
HTML
100%
International sales lift Pfizer 2Q profit
The American flag is seen reflected in the Pfizer world headquarters building, Tuesday, July 22, 2008 in New York.

Drug maker Pfizer says its second-quarter profit more than doubled as restructuring charges declined and the weak dollar...

Tri-City Herald Online:  Jul 24 2008 1:01AM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer's Net Rises on Global Sales
The world's largest drug company by sales, Pfizer Inc., reported an increase in its second-quarter profit, as international sales growth helped offset generic competition in the U.S.

Meanwhile, the No.

2 drug maker, GlaxoSmithKline PLC,...

Wall Street Journal Online:  Jul 24 2008 12:43AM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer Reports Second-Quarter 2008 Results
Pfizer Reaffirms Full-Year 2008 Revenue and Adjusted Diluted EPS(1) Guidance; On-Track to Achieve Total Cost-Reduction Target Second-Quarter 2008 Revenues of $12.1 Billion Compared with $11.1 Billion in the Year-Ago Quarter Second-Quarter...
SmartBrief:  Jul 23 2008 2:11PM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer Reports Second-Quarter 2008 Results
-- Pfizer Reaffirms Full-Year 2008 Revenue and Adjusted Diluted EPS(1) Guidance; On-Track to Achieve Total Cost-Reduction Target -- Second-Quarter 2008 Revenues of $12.1 Billion Compared with $11.1 Billion in the Year-Ago Quarter -- Second...
Business Wire via Yahoo!:  Jul 23 2008 11:26AM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer Reports Second-Quarter 2008 Results
- Pfizer Inc (NYSE: PFE): -0- See end of text prior to tables for notes.

Pfizer Inc (NYSE: PFE) today reported financial results for the second-quarter 2008.

The Company recorded revenues of $12.1 billion, an increase of 9% compared with...

Drugs.com:  Jul 23 2008 2:17PM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer Reports Second-Quarter 2008 Results
c (NYSE: PFE): ($ in millions, except per share amounts) Second-Quarter Year-to-Date ------------------------ ------------------------ 2008 2007 Change 2008 2007 Change -------- -------- ------ -------- -------- ------ Reported Revenues $ 12...
TradingMarkets:  Jul 23 2008 1:56PM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer Reports Second-Quarter 2008 Results
($ in millions, except per share amounts) Second-Quarter Year-to-Date ------------------------ ------------------------ 2008 2007 Change 2008 2007 Change -------- -------- ------ -------- -------- ------ Reported Revenues $ 12,129 $ 11,084 9...
Genetic Engineering News:  Jul 23 2008 1:01PM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer Reports Second-Quarter 2008 Results
- Pfizer Inc (NYSE: PFE): -0- ($ in millions, except per share amounts) Second-Quarter Year-to-Date ------------------------ ------------------------ -------- -------- ------ -------- -------- ------ Reported Revenues $ 12,129 $ 11,084 9% $...
Pharmalive.com:  Jul 23 2008 12:56PM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer Reports Second-Quarter 2008 Results
- Pfizer Inc (NYSE: PFE): -0- ($ in millions, except per share amounts) Second-Quarter Year-to-Date ------------------------ ------------------------ -------- -------- ------ -------- -------- ------ Reported Revenues $ 12,129 $ 11,084 9% $...
Pharma Live:  Jul 23 2008 12:11PM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer Reports Second-Quarter 2008 Results
Pfizer Inc (NYSE: PFE): -0- *T ($ in millions, except per share amounts) Second-Quarter Year-to-Date ------------------------ ------------------------ 2008 2007 Change 2008 2007 Change -------- -------- ------ -------- -------- ------...
Forbes.com:  Jul 23 2008 11:30AM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer Reports Second-Quarter 2008 Results
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc (NYSE: PFE): See end of text prior to tables for notes.

Pfizer Inc (NYSE: PFE) today reported financial results for the second-quarter 2008.

The Company recorded revenues of $12.1 billion, an...

Street Insider:  Jul 23 2008 11:20AM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer Q2 profit doubles on international sales, lower costs; reiterates FY08 outlook - Update 2
drug manufacturer Pfizer Inc.

(PFE | Quote | Chart | News | PowerRating) reported a profit for the second quarter that more than doubled, helped by lower restructuring charges and double-digit international revenue growth.

On an adjusted...

TradingMarkets:  Jul 23 2008 5:32PM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer Reports Second-Quarter 2008 Results
Pfizer Inc (PFE): ($ in millions, except per share amounts) Second-Quarter Year-to-Date 2008 2007 Change 2008 2007 Change Reported Revenues $ 12,129 $ 11,084 9% $ 23,977 $ 23,558 2% Reported Net Income 2,776 1,267 119% 5,560 4,659 19%...
Houston Chronicle:  Jul 23 2008 12:17PM
Matching: camptosar
Find similar documents
HTML
100%
Pfizer Profit Doubles, but Anti-Smoking Drug Lags
NEW YORK -- Pfizer Inc Wednesday said quarterly earnings more than doubled on higher sales of its prescription drugs and lower expenses, but its Chantix quit-smoking drug lost more than a third of its U.S.

sales amid safety concerns.

The...

MoneyNews.com:  Jul 23 2008 7:59PM
Matching: camptosar
Find similar documents
HTML
100%
International sales lift Pfizer 2Q profit
Associated Press Writer Today Pfizer said its second-quarter profit more than doubled as restructuring charges declined and the weak dollar helped lift overseas revenue, offsetting new generic competition and enabling the company to just...
Hartford Business Journal:  Jul 23 2008 7:01PM
Matching: camptosar
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.